Economic Impact Analysis: A Pocket-Sized Rapid, Multiplex PCR Diagnostic for Infection Testing for Self-Directed Healthcare

LabReady正在开发世界上第一个口袋大小的快速多重qPCR测试，允许全科医生，护士，A&E甚至患者在30分钟内同时诊断五种不同的可治疗感染，而无需数百万英镑的昂贵设备，熟练的技术人员和实验室延迟。该拟议项目旨在开发经济分析技术模型，并报告MyLabReady等首个口袋大小的快速多重qPCR诊断技术如何影响目标患者人群沿着自我导向的医疗保健途径。作为将这一创新和急需的技术部署到英国卫生和社会保健系统等市场的商业化过程的一个重要里程碑，该项目将对基础技术的成本效益和影响进行研究，包括经济模型，经济成本和结果成本与适当的比较。

LabReady is developing the world's first pocket-sized, rapid, multiplex qPCR test that allow GPs, nurses, A&E, and even patients to simultaneously diagnose five different treatable infections within 30 minutes and without millions of pounds of expensive equipment, skilled technicians, and lab delays. This proposed project aims to develop the economics analysis technical model and report of how a first-of-its-kind pocket sized and rapid, multiplex qPCR diagnostic technology like MyLabReady impacts target patient populations along a self-directed healthcare pathway. As a critical milestone of the commercialization process of deploying this innovative and much needed technology into a market like the English health and social care system, this project will conduct a study into the underlying technology's cost-effectiveness and impact, including an economic model, economic costs, and outcomes cost with an appropriate comparator.